Statistics
Publications
76
Citations
3.6K
H-Index
33
Active since
1982
Takayoshi Okabe is an author at The University of Tokyo specializing in pharmacology, life sciences, and drug discovery.
Publications per year
1982–2023
76
76
Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.
Masatoshi Kitagawa, Takayoshi Okabe, H Ogino et al. · PubMed · 1993 · 221 citations
1–5 of 76